Analysis and preliminary characterisation of the cytochrome P450 monooxygenases from Frankia sp. EuI1c (Frankia inefficax sp.) by Lau, I. et al.
ACCEPTED VERSION 
 
Ian C.K. Lau, René Feyereisen, David R. Nelson, Stephen G. Bell 
Analysis and preliminary characterisation of the cytochrome P450 monooxygenases from 
Frankia sp. EuI1c (Frankia inefficax sp.) 
Archives of Biochemistry and Biophysics, 2019; 669:11-21 
 
© 2019 Elsevier Inc. All rights reserved. 
This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 



























Authors can share their accepted manuscript: 
Immediately  
• via their non-commercial personal homepage or blog 
• by updating a preprint in arXiv or RePEc with the accepted manuscript 
• via their research institute or institutional repository for internal institutional uses or as part of an 
invitation-only research collaboration work-group 
• directly by providing copies to their students or to research collaborators for their personal use 
• for private scholarly sharing as part of an invitation-only work group on commercial sites with 
which Elsevier has an agreement 
After the embargo period  
• via non-commercial hosting platforms such as their institutional repository 
• via commercial sites with which Elsevier has an agreement 
In all cases accepted manuscripts should: 
• link to the formal publication via its DOI 
• bear a CC-BY-NC-ND license – this is easy to do 
• if aggregated with other manuscripts, for example in a repository or other site, be shared in 
alignment with our hosting policy 
• not be added to or enhanced in any way to appear more like, or to substitute for, the published 
journal article 
 
26 November 2020 
1 
 
Analysis and Preliminary Characterisation of the Cytochrome P450 Monooxygenases 
from Frankia sp. EuI1c (Frankia inefficax sp.)  
 
 
Ian C.-K. Lau,[a], René Feyereisen,[b], David R. Nelson,[c] and Stephen G. Bell*[a] 
[a] Department of Chemistry, University Adelaide, Adelaide, SA, 5005, Australia  
E-mail: stephen.bell@adelaide.edu.au 
[b] Department of Plant and Environmental Sciences, University of Copenhagen, Copenhagen, 
Denmark. 
[c] University of Tennessee Health Science Center, Dept. of Microbiology, Immunology and 




Frankia sp. EuI1c (Frankia inefficax sp.), contains 68 CYP encoding genes. 
 
The CYP189 family (21 members) has undergone gene duplication events classified as a 
“bloom”. 
 
Genes for eight [3Fe-4S] and one [2Fe-2S] cluster containing ferredoxins were identified 
 
Three CYP family from Frankia sp. EuI1c, were produced and purified using Escherichia coli  
 





Frankia bacteria are nitrogen fixing species from the Actinobacterium phylum which live on 
the root nodules of plants. They have been hypothesised to have significant potential for natural 
product biosynthesis. The cytochrome P450 monooxygenase complement of Frankia sp. EuI1c 
(Frankia inefficax sp.), which comprises 68 members, was analysed. Several members 
belonged to previously uncharacterised bacterial P450 families. There was an unusually high 
number of CYP189 family members (21) suggesting that this family has undergone gene 
duplication events which are classified as “blooms”. The likely electron transfer partners for 
the P450 enzymes were also identified and analysed. These consisted of predominantly [3Fe-
4S] cluster containing ferredoxins (eight), a single [2Fe-2S] ferredoxin and a couple of 
ferredoxin reductases. Three of these CYP family members were produced and purified, using 
Escherichia coli as a host, and their substrate range was characterised. CYP1027H1 and 
CYP150A20 bound a broad range of norisoprenoids and terpenoids. CYP1074A2 was highly 
specific for certain steroids including testosterone, progesterone, stanolone and 4-androstene-
3,17-dione. It is likely that steroids are the physiological substrates of CYP1074A2. These 
results also give an indication that terpenoids are the likely substrates of CYP1027H1 and 
CYP150A2. The large number of P450s belonging to distinct families as well as the associated 
electron transfer partners found in different Frankia strains highlights the importance of this 
family of enzymes has in the secondary metabolism of these bacteria. 
 











The Frankia genus is comprised of nitrogen fixing bacteria known to live on the root nodules 
of actinorhizal plants.[1] These are a group of flowering plants (angiosperms) characterised by 
their symbiotic relationship with the Frankia bacteria. This relationship allows the plants to 
live in harsh environments and diverse ecological conditions including volcanic ash fields, 
glacial till, sand dunes, and both water-saturated and dry soils.[2] The first named species in 
the genus was Frankia alni which lives in symbiosis with the Alder genus of flowering plants. 
Other strains of the bacteria are specific to different plant species. Phylogenetic analysis has 
revealed four distinct clusters among Frankia strains.[3] Cluster 1 is a broad group that contains 
strains such as CcI3 (F. casuarinae), ACN14a (F. alni), and QA3, and are also known to infect 
the Alnus (Alder) genus of flowering plants. Cluster 2 and 3 are known to be microsymbiots of 
a multitude of other flowering plants and include the species BMG5.1 (F. coriariae), BMG5.12 
(F. elaeagni) and EAN1pec.[4-8] The Frankia sp. EuI1c strain is classified in Cluster 4 
phylogeny, which are atypical Frankia strains.[9, 10] These strains were isolated from 
actinorhizal plant nodules, but were unable to re-infect the host plant, or were ineffective strains 
with other examples being the strains CN3 (F. saprophytica), M16386 (F. asymbiotica) and 
G2 (F. irregularis).[11] Frankia sp. EuI1c, isolated from the root nodules of Elaeagnus 
umbellate (Japanese silverberry) is abnormal within the Cluster 4 Frankia strains, as it is 
capable of reinfecting its host-plant after isolation. However, after re-infection the EuI1c strain 
forms ineffectual root nodules.[12] Recent studies have attributed its inability to form root 
nodules to the lack of nitrogen fixation genes within its genome.[13] Recent chemotaxonomic, 
phenotypic, phylogenetic and genomic studies on the strain, have led to the proposal of the 
name "Frankia inefficax sp.".[10] 
 
Frankia strains have a robust metabolism that includes nitrogen fixation, biosynthesis of 
secondary metabolites and energy-generating pathways. Recently the genomes of multiple 
Frankia sp. strains from each of the four clusters have been sequenced, and found to contain 
gene clusters related to secondary metabolite and natural product metabolism, xenobiotic 
degradation and heavy metal resistance.[11, 14-18] A genomic and proteomic study on the 
Frankia strains ACN14a, CcI3 and EAN1pec revealed natural products ranging from lipids, 
siderophores, fatty acids, steroids, modified amino acids, spore pigments and potential 
antibiotics (Figure S1).[14] This makes the metabolic and biosynthetic pathways of Frankia 
sp. strains attractive targets for understanding the synthesis of novel natural products. 
 
The genome of Frankia sp. EuI1c strain has been sequenced, revealing a large genome size of 
8.8 million base pairs (Mb).[9] Typical of Frankia bacteria, the EuI1c strain contains a high 
percentage of Guanine-Cytosine (GC) DNA base-pair content.[13] The entire EuI1c strain 
contains  7,000 protein encoding genes, including 68 cytochrome P450 monooxygenase 
(P450) genes, which is an unusually high number making up close to 1% of the total gene 
count. These P450 enzymes carry out oxidative transformations, including hydroxylations, as 
well as other more complex reactions.[19-22] They are heme monooxygenases and utilise 
dioxygen which is activated by the addition of two electrons from NAD(P)H. In bacteria these 
reducing equivalents are most often supplied by ferredoxin reductase and ferredoxin 
proteins.[23, 24] P450 enzymes are capable of catalysing their reactions with high selectivity 
and under ambient conditions.[21] The P450s within Frankia sp. EuI1c are hypothesised to 
play roles in facilitating the biosynthesis and/or metabolism of the various secondary 
metabolites and natural products the Frankia species are known to generate or encounter.[1, 
14] The combination of these factors result in P450s, such as those found in Frankia bacteria, 




Here we present the phylogenetic analysis of the P450 enzyme genes from the bacterium 
Frankia sp. EuI1c along with any associated ferredoxin and ferredoxin reductase genes. We 
also report the production and purification of selected P450 enzymes including the 
identification of their likely substrates through enzyme binding assays. These results presented 
here provide the first insight into the potential functions of the P450s from Frankia sp. EuI1c 






Reagents, solvents and organic substrates were purchased from Sigma-Aldrich, VWR, 
Fluorochem, Acros Organics and Tokyo Chemical Industry. Antibiotics, isopropyl β-D-
thiogalactopyranoside (IPTG) and dithiothreitol (DTT) were purchased from Astral Scientific. 
T4 DNA ligase was from Lucigen and restriction enzymes for molecular biology were from 
New England Biolabs. KOD hot start polymerase, used for the polymerase chain reaction 
(PCR) steps, and the pET26a vector were from Merck Millipore. The genomic DNA of Frankia 
sp. EuI1c was generously provided by Prof. Louis Tisa, University of New Hampshire. General 
DNA and microbiological experiments were carried out by standard methods. 
UV/Vis spectra and spectroscopic activity assays were recorded at 30 ± 0.5 oC on an Agilent 
Cary 60 or Cary 5000 UV-vis spectrophotometer. Protein chromatography was performed on 
AKTA (GE healthcare) and GradiFrac (Amersham Pharmacia) systems. 
2.2 Bioinformatics and gene cloning  
CYP family and subfamily assignments were made by Dr. David Nelson according to the P450 
nomenclature[25] and are used as given in the National Centre for Biotechnology Information 
(NCBI) database.  
2.2.1 Rare Codon Analysis  
The %MinMax algorithm was used to analyse rare codon clusters (RCC) in P450 genes. This 
algorithm compares the given mRNA sequence of the hypothetical protein with all the rarest 
codons (minimum) and the most common codons (maximum) to determine the frequency of 
codon usage. The online web tool LaTcOm was used for all RCC analyses.[26] 
2.2.2 Gene cloning 
The CYP genes chosen for study were amplified by PCR using oligonucleotide primers (Table 
S1). They were amplified by 30 cycles of strand separation at 95 ºC for 45 s followed by 
annealing at 55 ºC for 30 s and extension at 68 ºC for 80 s. incorporated into the pET26 vector 
(Merck-Millipore) between NdeI and HindIII (or XhoI see Table S1) restriction sites. 
Successful incorporation of the genes and mutants into each vector was confirmed by 
restriction enzyme digest followed by DNA sequencing (AGRF, Adelaide node) using the 
primers; T7 promoter, T7 terminator appropriate for the pET26 parent vector (Merck-
Millipore).  
2.3 Protein Expression and Purification  
Growth media constituents. (L-1) 
LB: Tryptone (10 g), yeast extract (5 g), NaCl (10 g)  
SOC: Tryptone (20 g), yeast extract (5 g), MgCl2 (1 g), NaCl (0.5 g), KCl (0.2 g), glucose 
(0.2% w/v)  
2x YT: Tryptone (16 g), yeast extract (10 g), NaCl (5 g)  
Trace Elements: Na2EDTA (20.1 g), FeCl3.6H2O (16.7 g), CaCl2.H2O (0.74 g), CoCl2.6H2O 
(0.25 g), ZnSO4.7H2O (0.18 g), MnSO4.4H2O (0.132 g), CuSO4.5H2O (0.10 g)  
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2.3.1 Recombinant P450 Production 
Plasmids (pET26a) containing the P450 genes were transformed in BL21(DE3) competent E. 
coli cells (New England Biolabs). These were held in ice for 45 min, heat shocked (42 C for 
1 min) and subsequently grown in SOC media (1 hour, 37 C, 200 rpm) before incubation on 
a LB plate containing 30 µg L-1 kanamycin (37 C, 16 hours).  
A small scale growth was first performed for expression testing. For these a single colony 
inoculated in 50 mL 2x YT containing 30 µg mL-1 kanamycin and 150 µL of trace elements. 
The cultures were grown at 37 oC for  4 hours (150 rpm). The incubator temperature was 
lowered to 18 C for 1 hour before the recombinant protein production was induced by 0.25 
mM IPTG (from a stock of 0.5 M in water). The cultures were grown for a further 18 hours at 
100 rpm. The cells were harvested from the culture by centrifugation at 5,000 g for 20 min. An 
indication of the levels of folded P450 was assessed by visual inspection of the cell pellet, with 
red colouration indicating P450 formation. In order to determine whether the red colour 
observed was from soluble protein, the pellets were resuspended in 4 mL of Bacterial Protein 
Extraction Reagent (ThermoFisher Scientific) per 1 g of cell pellet and stirred for 20 min. Cell 
debris was removed by centrifugation at 4,000 rpm for 10 min. The protein supernatant was 
loaded onto a 12% SDS gel and analysed by gel electrophoresis in GTS buffer (2.5% glycerol, 
20 mM Tris pH 8, 25 mM NaCl).  
For larger scaler scale growths a single colony was inoculated into each of 5 x 500 mL 2x YT 
(Yeast Extract Tryptone) containing 30 µg mL-1 of kanamycin and 1.5 mL trace elements and 
grown at 37 oC 14 hours at 100 rpm. The incubator temperature was lowered to 18 oC for 1 
hour before the addition of 0.02% v/v benzyl alcohol and 2% v/v ethanol. After a further 1 
hour, protein production was induced by 0.25 mM IPTG (from a stock of 0.5 M in water). The 
cultures were then grown for a further 48 hours. The cells were harvested from the culture by 
centrifugation at 5,000 g for 10 min and then resuspended in 200 mL Tris buffer (50 mM Tris, 
pH 7.4, 1 mM DTT). The resuspended cells were lysed by sonication using an Autotune CV334 
Ultrasonic Processor equipped with a standard probe (136 mm x 13 mm; Sonics and Materials, 
US) using 30 x 20 s pulses with 40 s intervals. Cell debris was removed by centrifugation at 
40,000 g for 30 min. The supernatant was loaded on to a DEAE Fastflow Sepharose column 
(XK50, 200 mm x 50 mm; GE Healthcare) and the protein was eluted using a linear salt 
gradient of KCl (100 - 400 mM) in Tris buffer, pH 7.4, at a flow rate of 6 mL min-1. The red 
protein-containing fractions were collected and concentrated by ultrafiltration with a 10,000 
kDa unit (Vivacell 100, Sartorius). The protein was desalted via gel filtration on a G-25 
Sephadex medium column equilibrated with Tris buffer, pH 7.4. After concentration by 
ultrafiltration, the protein was loaded onto an Source-Q ion exchange column (80 mm x 30 
mm; GE Healthcare) and eluted with solutions A (Tris buffer) and B (1 M KCl in Tris buffer) 
at a gradient of 10% - 40% solution B over 110 min at a flow rate of 6 mL min-1. Purified 
fractions were combined and concentrated by ultrafiltration (10,000 kDa exclusion membrane, 
50 mL). An equal volume of glycerol was added to the concentrated fractions, and the solution 
was filtered through a 0.2 µm sterile syringe filter and stored at -20 oC. Glycerol was removed 
immediately before use by gel filtration on a 5 mL PD-10 column (GE Healthcare) by eluting 
with 50 mM Tris, pH 7.4. 
To quantify the purified P450 enzymes, a carbon monoxide difference spectrum was measured. 
The enzyme was diluted in 50 mM Tris, pH 7.4, in 0.5 mL. Sodium dithionite (< 1 mg) was 
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added and CO was gently bubbled through the sample. The spectrum was then recorded 
between 700 nm and 300 nm. The P450 protein concentrations were estimated using the 
extinction coefficient at 446-490 = 91 mM
-1cm-1 for the CO spectrum minus the reduced ferrous 
spectrum.[27] Using this value, the extinction coefficients for the ferric resting state of the CYP 
enzymes were calculated to be as follows; CYP1027H1 418 = 130 mM
-1cm-1 and CYP150A20 
418 = 151 mM-1cm-1. 
2.3 Substrate Binding Assays  
2.3.1 Spin-state Shift Assays  
P450 proteins were diluted to 0.5 - 1.0 µM using 50 mM, pH 7.4 Tris buffer, and the UV/Vis 
spectra was recorded. Aliquots of substrates (1 µL, 100 mM in ethanol/DMSO) were added to 
500 µL of the protein until the low-spin (LS) (≈ 418 nm) to high-spin (HS) (≈ 390 nm) shift 
did not proceed further. The weighted averages of the spectra of camphor-free and camphor-
bound P450cam (≈ 0% to ≈ 100% HS) were used to estimate the % HS of the P450 
enzymes.[28] 
2.3.2 Dissociation Constant Assays 
P450 proteins were diluted to 0.5 - 2.0 µM using 50 mM Tris, pH 7.4, in 2.5 mL. Increasing 
aliquots of substrate (0.5 - 3 µL) were added using a Hamilton syringe from a 1, 10 and then a 
100 mM stock solution in ethanol and/or in DMSO. The samples were mixed and the peak-to-
trough difference in absorbance was recorded on the UV spectrophotometer between 700 nm 
and 250 nm. Aliquots of substrate were added until the peak-to-trough difference did not shift 
any further. The cumulative volume of each solution added was no more than 10 µL. The 
dissociation constants, Kd, were obtained by fitting the peak-to-trough difference against 
substrate concentration to a hyperbolic function (Equation 2)  




Where ∆A is the peak-to-trough absorbance difference, ∆Amax is the maximum absorbance 





3 Results and Discussion 
 
3.1 Analysis of the P450 content of Frankia sp. EuI1c 
Frankia sp. EuI1c has 68 different P450 encoding genes within its genome (Table S2). These 
were named using the standard P450 nomenclature (Table S2).[25, 29] A phylogenetic tree of 
P450s from Frankia sp. EuI1c was created along with related P450s from a range of bacteria 
(Figure 1). While many of these from Frankia sp. EuI1c were primarily related to P450s from 
other Frankia species, a few are related to known species from other organisms. For example, 
CYP147F19 was related to CYP147G1 (45%, sequence identity) and CYP150A20 was related 
to CYP150A6 (55%), both of which are from Mycobacterium marinum M.[30-32]  
 
Of the 68 P450 superfamily members 21 belonged to the CYP189 family (11 members of A, 6 
members of B and 2 members of the C subfamilies and one each from those of E and F). This 
type of gene duplication and lineage-specific expansions in CYP subfamilies have been named 
‘blooms’.[33] While blooms have been reported in eukaryotes and in fungi they have yet to be 
extensively observed in prokaryotes. Analysis of other members of the Frankia genus revealed 
a contrasting picture. Frankia species such as ACN14a (F. alni), ARgP5 (F. canadensis) and 
CcI3 (F. casuarinae) (all cluster 1) contain no genes encoding CYP189 family members (they 
have between 14 and 51 P450 encoding genes). However, the Frankia sp. EAN1pec (cluster 3, 
15 out of 46), F. irregularis (cluster 4, 18 out of 64), sp. EUN1f (cluster 1, 15 out of 69) and 
F. asymbiotica (cluster 4, 17 out of 76) all show a similar “bloom” of CYP189 family members. 
F. elaeagni (strain BMG5.12, cluster 3) contained eight CYP189 family members (out of 31 
P450 genes, See Table S3 for more details). The data highlights that the number of P450 
encoding genes is not consistent across the Frankia species (Table S3). This infers that different 
species have evolved to adapt to their symbiotic environments. It is commonly held that 
eukaryotes have a much smaller effective population size (Ne) than prokaryotes, a key 
determinant of the longer half-life of duplicated genes which favours the generation of 
blooms.[34] Duplicated genes, when retained, have a greater probability of preservation by 
neofunctionalization in prokaryotes, while in eukaryotes the more common duplicates are more 
likely to be maintained in the genome by subfunctionalization. The CYP189 blooms onserved 
in some Frankia species may therefore constitute a set of P450s with new functions. The 
symbiotic nature of different Frankia species may also be a factor in determining the relative 
CYPomes sizes, in that Ne for Frankia species may be significantly smaller than for free-living 
actinobacteria, thus relaxing selection and allowing the generation of blooms. At the same time, 
the variety of CYP genes may be beneficial to the peculiar ecology of each species of Frankia.  
 
The role of the CYP189 family of enzymes is currently unknown hampering an understanding 
into why it might be a favourable candidate for gene duplication. CYP189A1 from 
Mycobacterium smegmatis was hypothesised to be involved in cholesterol metabolism as its 
gene was upregulated in response to this steroid.[35] However, after production, purification 
and biochemical analysis no substrate binding response or activity was observed for this and 
several other substrates.[36]  
 
The EuI1c genome has 6 genes encoding members of the CYP107 family and 4 of the 
CYP150A subfamily (Table S2). There were also many P450 family members which are 
present in other actinobacteria such as Mycobacteria, Rhodococcus and Streptomyces including 
CYP108 (x2), CYP124 (x2), CYP125 (x3), CYP142 (x1), CYP147 (x1), CYP155 (x1), 
CYP157 (x4) and CYP190 (x1).[37] There were nine families where the P450 enzymes from 
this bacterium are the first named member (CYP1242A1, CYP1162A1, CYP1074A1, 
CYP1316A1, CYP1323A1, CYP1073A1, CYP1163A1 and CYP1161A1, Table S2).  
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The EXXR sequence motif is conserved in all the P450s in Frankia sp. EuI1c with the 
exception of each of the four CYP157 family members where the arginine was replaced by a 
tryptophan residue (Table S2).[38] The P450 enzymes encoded by these four genes also lacked 
the acid alcohol pair which facilitates oxygen activation in the P450s.[20] In these CYPs the 
acid group was replaced with a glutamine or leucine and the alcohol with a proline or alanine 
(Table S2). The acid residue was replaced in eight of the other CYPs including CYP1073A1 
(Ser), CYP254A9 (His), CYP107BG3 (Val), CYP109K1 (Leu), CYP155D2, CYP150A23, 
CYP1034A3 and CYP1161A1 (all Gly). Based on this sequence data several of the P450s from 
Frankia sp. EuI1c would appear to have evolved to have different substrates or functions to 
those previously characterised. 
 
 
Figure 1 A phylogenetic tree of the 68 P450s from Frankia sp. EuI1c and related bacterial 
P450s. These include CYP189A7 (Mycobacterium ulcerans), CYP190A1 (Mycobacterium 
smegmatis), CYP123A1, CYP125A1, CYP125A1, CYP142A1, CYP51B1 (all Mycobaterium 
tuberculosis), CYP109B1 (Bacillus subtilis), CYP108D1 (Novosphingobium 
aromaticivorans), CYP101A1 (Pseudomonas putida), CYP159A1, CYP157A1 (both 
Streptomyces coelicolor), CYP254A1 (Rhodococcus sp. RHA1), CYP102A1 (Bacillus 
megaterium), CYP105D1 (Streptomyces griseus), CYP107A1 (Saccharopolyspora erythraea), 
CYP147G1 and CYP150A6 (both Mycobacterium marinum). The tree was computed by the 
CLUSTAL Omega server at EBI (http://www.ebi.ac.uk/Tools/msa/clustalo/).[39] The tree was 
midpoint rooted and drawn in Figtree v1.4.3. 
 
The genome sequence of the bacterium was analysed in more detail in order to select the P450s 
to be investigated further. The P450 catalytic cycle requires that electrons and protons to be 
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transferred to the heme.[20] In the majority of bacterial P450 systems, both a ferredoxin and a 
ferredoxin reductase are required for the electron transfer from NAD(P)H to the P450.[24] 
Identification of the ferredoxins and ferredoxin reductases for the P450s from Frankia sp. 
EuI1c would enable the P450 systems to be analysed in greater detail. Of the 68 P450 genes of 
this bacterium, nine of them are coupled with a ferredoxin gene. Furthermore only two out of 
these nine are clustered with a ferredoxin reductase gene (Table 1). This close arrangement of 
these types of genes infers that they are the likely electron transfer partners to their clustered 
P450s.[40, 41] 
 
Table 1 The P450 genes of Frankia sp. EuI1c which are clustered with ferredoxins and 
ferredoxin reductase electron transfer partners. The gene size molecular weight, and non-
standard residue of ferredoxins or cofactor of associated ferredoxin reductases if known are 
provided. More details on the nine P450 genes associated with these ferredoxins are also given 
in Table 2 (other P450s are described in Table S2). [a] FraEuI1c5082 is a ferredoxin 
reductase/ferredoxin fusion protein. 









FraEuI1c_5370 FraEuI1c_5369 189 6.75 [3/4Fe-4S] His 
FraEuI1c_5333 FraEuI1c_5334 195 6.67 [3/4Fe-4S] Ser 
FraEuI1c_2495 FraEuI1c_2494 216 7.32 [3/4Fe-4S] His 
FraEuI1c_1414 FraEuI1c_1415 213 7.67 [3/4Fe-4S] Thr 
FraEuI1c_4132 FraEuI1c_4131 219 7.09 [3/4Fe-4S] Ser 
FraEuI1c_5082[a] FraEuI1c_5083 1632 57.9 [3/4Fe-4S] Tyr 
FraEuI1c_5464 FraEuI1c_5466 189 6.71 [3/4Fe-4S] His 
FraEuI1c_4178 FraEuI1c_4179 204 6.81 [3/4Fe-4S] Ser 
FraEuI1c_3227 FraEuI1c_3226 319 10.8 [2Fe-2S] - 
      








FraEuI1c_3228 FraEuI1c_3226 1251 43.2 PdR FAD 
FraEuI1c_5082[a] FraEuI1c_5083 1632 57.9 - - 
 
One of these FraEu1c_3227 encodes a [2Fe-2S] cluster protein and was also located next to a 
ferredoxin reductase gene (Table 1). This ferredoxin reductase gene, FraEuI1c_3228, is 
therefore clustered with the [2Fe-2S] ferredoxin (FraEuI1c_3227) and CYP1163A1 
(FraEu1c_3227) forming a complete electron transfer system. Another of the potential electron 
transfer partner genes FraEu1c_5082 is a fusion of a ferredoxin reductase and ferredoxin. This 
gene is next to that of CYP147F19 (FraEuI1c_5082). The ferredoxin component of this fused 
gene is a single [3Fe-4S] cluster system.[30] The remaining ferredoxin genes encode proteins 
whose sequences indicate that they would encode [3Fe-4S] or [4Fe-4S] cluster containing 
ferredoxins (Table 1).[30, 42] These types of iron-sulfur ferredoxins generally contain 
sequence motifs of CXX?XXC(X)nCP.[43] The cysteine residues in this motif bind to the iron 
sulfur cluster and if the variable residue at position ? is a cysteine the cluster type is normally 
a [4Fe-4S]. If it is an alanine or glycine it would be a [3Fe-4S] iron-sulfur cluster ferredoxin. 
All the potential [3Fe-4S] ferredoxins in Frankia sp. EuI1c have non-standard residues at the 
"?" position in the motif.  Previous studies indicate that these ferredoxins contain [3Fe-4S] 
clusters but that the identity of the variable residue affects the redox properties of the 
ferredoxin.[30] The ferredoxin genes clustered next to the P450s Frankia sp. EuI1c contain 




Given that one of the associated ferredoxin reductase genes is fused to its own [3Fe-4S] cluster 
domain and the other is linked to a [2Fe-2S] containing ferredoxin gene, it seems likely that 
this bacterium could contain additional ferredoxin reductases that can support the other [3Fe-
4S] ferredoxins linked with these P450s. These would facilitate the electron transfer between 
NAD(P)H and the ferredoxin and would allow detailed turnover assays to be undertaken. It is 
of note that, like other actinobacteria (for example, Mycobacterium marinum) there are 
significantly more ferredoxins of this [3Fe-4S] type in the genome.[30]  
 
3.2 Production and Purification of selected P450s from Frankia sp. EuI1c 
Strains of Frankia bacteria are known to have a high guanine-cytosine (GC) content. The 
Frankia sp. EuI1c genome contains 72.31% GC content compared to 50% in E. coli.[9] The 
GC content for the 9 selected P450s ranged from 69-75% (Table 2). Given such a large 
difference in base content the Frankia CYP genes may possess codons whose tRNA are present 
in low amounts in E. coli (rare codons).[44, 45] Analysis of these 9 P450 genes for rare codon 
clusters (RCC) revealed multiple RCCs which could impair protein production using E. coli 
(Table 2, Figure S2).[46] The rare codon percentage was significant, ranging from 8-16% 
(Table 2).  
 
Small scale expression tests of the nine P450s in Table 2 were undertaken to observe and 
identify which of these might be able to be produced at a level appropriate for further 
investigation. The level of P450 expression was ranked according to the intensity of the red 
colour, which is characteristic of the heme-containing enzyme, within the cell pellets: 
CYP1027H1 > CYP150A20 > CYP1074A2 > CYP1034A4 > CYP147F19  CYP150A21  
CYP1161A1  CYP1034A5  CYP1163A1. While the cell pellet containing CYP1027H1 was 
dark red in colour that of CYP150A20 was pink. The pellets of CYP1074A2 and CYP1034A4 
were a lighter shade of pink indicative of a low level of protein. Little to no P450 holoenzyme 
was produced for CYP147F19 and the other Frankia P450s tested here, as determined by the 
beige coloured cell pellets. 
 
Table 2 Gene size, protein molecular weight and GC content of the P450s from Frankia sp. 
EuI1c. The codons encoding for arginine (AGG, AGA, CGG, CGA), isoleucine (ATA), and 
proline (CCC) were considered rare codons in E. coli (< 0.4% codon usage).[45] [26, 44] 
 









FraEuI1c_2494 CYP1027H1 1248 46.47 72 11 
FraEuI1c_5334 CYP150A20 1275 47.30 70 7 
FraEuI1c_1415 CYP1074A2 1272 47.23 68 10 
FraEuI1c_4131 CYP1034A4 1248 45.87 70 10 
FraEuI1c_5369 CYP150A21 1380 49.83 70 8 
FraEuI1c_5083 CYP147F19 1272 45.91 75 16 
FraEuI1c_5466 CYP1161A1 1215 44.17 72 9 
FraEuI1c_4179 CYP1034A5 1260 46.33 72 8 
FraEuI1c_3226 CYP1163A1 1263 48.20 69 11 
 
The four P450s that showed any evidence of fully folded enzyme production were grown on a 
scale viable for protein purification. SDS-PAGE gel analysis showed that the E. coli cells 
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generated a protein of between 44-48 kDa about the size expected for the P450 enzymes above 
(Table 2, data not shown). Large scale growth of E. coli producing CYP1027H1 resulted in a 
significant quantity of a red coloured soluble protein after cell lysis and centrifugation to 
remove cell debris. The levels of purified protein obtained with CYP150A20 and CYP1074A2 
was lower and correlated with the colour of the cell pellet described above (Figure S3). While 
the pellet of CYP103A4 was similar in colour to CYP1074A2, little to no soluble P450 protein 
was isolated (Figure S3).  
 
The purified P450s were analysed using UV/Vis spectroscopy (Table 3, Figure S3). In order to 
determine the concentration of the P450s, the spectra of the ferrous carbon monoxide (CO) 
bound form was determined. CYP1027H1 and CYP150A20 each showed an almost complete 
shift (95%) from to the CO-bound ferrous form (Figure S4). A small shoulder was observed 
at 420 nm for both the CO bound reduced P450s (Figure S4). The ferrous-CO assay for 
CYP1074A2 produced a different spectrum. After reduction, the P450 spectrum peak shifted 
to 426 nm (Figure S4). Once CO was bubbled into the mixture, a large peak at 422 nm peak 
was observed (Table 3). This indicated formation of the inactive species "P420" form which is 
thought to arise from protonation of the cysteine thiolate, resulting in thiol ligation to the heme 
iron.[47, 48] This suggested that either all of the CYP1074A2 protein is present in an inactive 
or denatured form, or the enzyme is sensitive to the method of reduction or addition of CO. 
The inactive form of P450s can be induced by treatment with acetone or exposing the P450 to 
a high pressure environment.[49, 50] It was subsequently found that CYP1074A2 could bind 
steroids with high affinity, inducing a full type I spin state shift (95% high-spin, see Section 
3.3.3). Additional CO bound spectra for CYP1074A2 were obtained in the presence of the 
substrate 4-androsterene-3,17-dione (Figure S4). After the addition of CO, a proportion of the 
spectra displayed the characteristic 450 nm peak (Table 3, Figure S4).  
 
Table 3 The UV/Vis wavelengths of the absorbance peak maxima for the ferric, ferrous and 
ferrous-CO spectra of CYP1027H1, CYP150A20 and CYP1074A2. 
 
P450 Ferric (nm) Ferrous (nm) Ferrous-CO (nm) 
CYP1027H1 418 410 447 
CYP150A20 418 414 448 
CYP1074A2 417 426 422 
CYP1074A2+substrate 393 393 449 and 421 
 
 
Through the CO difference assays, the extinction coefficients of CYP1027H1 and CYP150A20 
in their resting states were calculated (CYP1027H1 418 = 130 mM
1cm1 and CYP150A20 418 
= 151 mM1cm1.The amount of CYP1027H1 protein expressed per litre of cell culture was 
approximately 60 mg L1. That of CYP150A20 being 14.8 mg of protein per litre of cell culture. 
The level of CYP1074A2 generated was estimated to be  2 mg L1. 
 
The level of protein production using E. coli as a host for many of the tested P450s from 
Frankia sp. EuI1c was poor. Analysis of the DNA sequence of the genes revealed a substantial 
number of rare codons which may slow down translation resulting in lower expression levels. 
However, the RCC content of the genes did not directly correlate to the levels of production of 
the enzymes. While the P450 genes from Frankia sp. EuI1c showed high GC content they did 
not appear to have an unsustainable number of rare codons but several had extensive RCCs. In 
order to improve the poor expression caused by these clusters, codon optimised genes for E. 
coli or an alternative host could be used. However, we cannot rule out that poor heme 
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incorporation or protein folding is the cause for the low level of formation of P450 holoenzyme. 
Further optimisation of the production of the majority of the P450s is required in order to enable 
more detailed analysis of their function. 
 
3.3 Assessment of the potential substrate range of CYP1027H1, CYP150A20 and 
CYP1074A2 
The first step of the P450 catalytic cycle often involves the displacement of the distal water 
ligand by an appropriate substrate.[20] When this occurs a low spin to high spin (HS) state shift 
occurs and this change can be monitored by UV/Vis spectroscopy as it results in a blue-shift in 
absorbance of the main Soret peak from approximately 418 nm to 390 nm. In order to help 
determine which substrates to test with each of the P450s from Frankia sp. EuI1c, the amino 
acid sequence of the different P450s were initially compared to P450s of known function. A 
BLAST search was undertaken for each of the P450s to find others with close sequence 
identities.[51] As many of the Frankia P450s assessed here did not share significant sequence 
identity to functionally characterised enzymes other classes of molecules were also tested. 
These included cyclic mono- and sesqui-terpenoids, short and medium chain (C6-C12) linear 
alkanes, benzene and polycyclic aromatic hydrocarbons, fatty acids, substituted phenols, 
substituted benzoic acids and steroid compounds. 
 
3.3.1 Investigation of Substrate Binding to CYP1027H1 
CYP1027H1 is most closely related to other uncharacterised P450s from Frankia, sharing up 
to 53% amino acid sequence identity with these P450 enzymes and others from Streptomyces, 
Gordonia, Mycobacterium, Thermomonospora, Nocardia and Rhodococcus bacteria (Table 4). 
It showed low amino acid sequence identity (28-34%) to the terpenoid oxidising enzymes 
CYP101A1 (P450cam), CYP176A1 (P450cin) and CYP108A1 (P450terp, Table 4).[52-54] 
CYP1027H1 was also 25% identical to the amino acid sequence of CYP109B1 from Bacillus 
subtilis (Table 4).[55]  
 
A range of compounds including norisoprenoids, monoterpenoids, sesquiterpenoids, steroids 
and fatty acids were screened with CYP1027H1. While certain mono- and sesqui-terpenoids, 
induced spin state shifts, no shift was observed for any of the fatty acids and steroids (Figure 2 
and Figure S5 and S6). The norisoprenoids, -ionone, β-ionol and β-damascone all induced 
commensurate spin state shifts of between 40-50% in CYP1027H1 (Figure 2). They also 
exhibited similar binding affinities to the enzyme (Kd = 7.6, 12 and 12 µM, respectively, Figure 
2 and Figure S7). Unexpectedly, β-ionone did not induce any spin state shift in CYP1027H1, 
despite having a very similar structure to the other norisoprenoids. Bornyl acetate, fenchyl 
acetate and 4-tert-butylcyclohexyl acetate, which all possess a cyclohexane group with oxygen-
containing carbon chain substituents similar to the norisoprenoids, induced a spin state shift in 
CYP1027H1 (35-40%, Figure S5 and S6). The binding affinities were similar to those of the 
norisoprenoids (Kd = 8.4, 8.6 and 11 µM, respectively, Figure 2 and Figure S7). 
 
Decalin (trans-decahydronapthalene) induced a HS state shift (60%) when added to 
CYP1027H1 and also had a high binding affinity (Kd = 4.9 µM, Figure S6 and S7). However, 
the related compound tetralin, which contains an aromatic ring, induced only a 30% spin shift 
and the binding affinity was significantly lower (Kd = 52 µM, Figure 2, Figure S5). 
Naphthalene, which is comprised of two interconnected unsaturated benzene rings, induced a 
negligible spin state shift (Figure S6). This suggests that saturated cyclic rings are a core 




Larger compounds such as ambroxide, which has a structure consisting of two fused 
cyclohexane rings, similar to trans-decahydronaphthalene, but with an additional 5 membered 
ring carbon ring containing an ether oxygen (Figure 2), induced a 60% spin state shift of the 
heme iron upon addition to CYP1027H1. This substrate bound with the highest affinity to the 
enzyme (Kd = 0.7 µM, Figure 2 and Figure S5). A 50% spin state shift in CYP1027H1 was 
also observed when sclareolide was added. Sclareolide is structurally related to ambroxide but 
possesses an extra carbonyl group (Figure 2 and Figure S6). The dissociation constant for 
sclareolide was unable to be determined as larger amounts of substrate were required to saturate 
the spectrum and this was beyond the aqueous solubility limit. However, it had a lower affinity 
than ambroxide as judged by the significantly reduced response of the difference spectrum to 
substrate addition. These saturated cyclic ring containing compounds are promising potential 
substrates for CYP1027H1. 
 
Table 4 The amino acid sequence identity of CYP1027H1 with other P450s. These were 
determined using a BLAST sequence search on the NCBI database. Three additional similar 
P450 enzymes were found in Frankia sp. Iso899 (47-49% sequence identity, not shown in the 
Table) along with others in other Frankia species including Frankia sp. QA3 (47%). Other 
strains of Mycobacteria and Nocardia also contained enzymes which shared 40-45% sequence 
identity. Note; CYP1027A1 and CYP1027B1 are from Frankia alni ACN14a (sequence 
identity 41 and 47%, respectively). The P450 name is given, where it has been assigned; if not 
the Genbank protein ID or NCBI accession number is provided. [a] Max Score 835. 








WP_022912145.1 Frankia sp. Iso899 429 53% - - 
WP_022914489.1 Frankia sp. Iso899 393 49% - - 
KOV68049.1 Streptomyces sp. NRRL WC-3618 384 49% - - 
GAC70340.1 Gordonia soli NBRC 108243 339 46% - - 
CQD18807.1 Mycobacterium europaeum 335 45% - - 
ACY98928.1 Thermomonospora curvata 323 47% - - 
PPJ16295.1 Nocardia nova 323 45% - - 
SMG27105.1 Rhodococcus rhodochrous J3 321 44% - - 
CYP254A1 Rhodococcus sp. RhA1 197 35% - - 
CYP101D1[41] Novosphingobium 
aromaticivorans 
173 34% camphor 3LXH 
CYP127A1 Sinorhizobium sp. NGR234 178 31% - - 
CYP143A1 Mycobacterium tuberculosis 198 35% - - 
CYP101A1[56] Pseudomonas putida 164 29% camphor 2CPD 
CYP176A1[52] Citrobacter braakii 157 29% 1,8-cineole 1T2B 
CYP108A1[53] Pseudomonas sp. 156 28% -terpineol 1CPT 
CYP109B1[55] Bacillus subtilis 134 25% fatty acids 4RM4 
 
Overall CYP1027H1 had a broad substrate range. The majority of these substrates contain 
oxygen containing substituents. These include ketone, ester, lactone, ether and alcohol groups, 
suggesting that the oxygen atom may interact with hydrophilic active site residues of 
CYP1027H1. These substituents, are hydrogen-bond acceptors/donors and are likely to interact 
with amino acids that contain hydrogen-bond donating side chains. However, these 
functionalities appear to be less important for CYP1027H1 than in other P450 systems for 
example P450cam (CYP101A1) and P450cin (CYP176A1).[57, 58] For example, trans-




Figure 2 Selected compounds assessed with CYP1027H1. Percentage high spin (HS) is 
denoted as % HS. The dissociation (Kd) is given as the mean ± S.D. with n  3 and given in 
µM. The dissociation constant of sclareolide and naphthalene were not determined due to 
insolubility of substrate preventing full analysis. β-Ionone did not induce an observable spin 




3.3.2 Investigation of Substrate Binding to CYP150A20 
CYP150A20 has a high sequence similarity (83-88%) to other uncharacterised Frankia P450s 
(Table 5). It is also has a 55-64% amino acid sequence identity with CYP150 family members 
from Mycobacterium and Blastococcus species. For example, CYP150A6 and CYP150A5, 
both from Mycobacterium marinum species share 50% and 55% amino acid sequence identity, 
respectively with CYP150A20 (Table 5).[32] The three other CYP150A subfamily members 
of Frankia sp. EuI1c shared 50-51% (A21, A22 and A23) amino acid sequence identity to 
CYP150A20 (Table 5). The closest other structurally characterised P450s are CYP108A1 
(P450terp) and CYP109B1, which have a low amino acid sequence identity at 32% (Table 5).  
 
Members of the CYP150 family has been reported to oxidise polycyclic aromatic hydrocarbons 
and CYP150A5 from M. marinum has been demonstrated to bind a range of compounds 
including norisoprenoids and terpenoid based substrates including the aromatic sesquiterpene 
guaiazulene (1,4-dimethyl-7-isopropylazulene).[32, 59] Therefore CYP150A20 was screened 
with a range of aromatic hydrocarbons, fatty acids, monoterpenoids and steroids (Figure 3). 
Steroids, such as testosterone, and fatty acids did not induce any spin state shift.  CYP150A20 
shares 27% amino acid sequence identity with CYP1027H1 and some of the compounds 
screened with this P450 displayed an affinity towards CYP150A20 (Figure 2 and 3 and Figure 
S8-S10).  
 
A number of norisoprenoids were able to induce spin state shifts in CYP150A20. β-Ionone, β-
damascone and β-ionol, all induced shifts to 40% HS, and displayed moderate binding affinity 
(Kd = 107, 74 and 107 µM, respectively; Figure 3 and Figure S8 and S9) These three 
compounds are very similar in structure and only differ in the position of their functional 
groups, such as the ketone and alkene in the butenone moiety. Although these norisoprenoids 
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induced the highest spin state shifts compared to the all other substrates tested here, the binding 
affinities were relatively low. This suggested that while they bind they are not an optimal fit 
for the substrate binding pocket. 
 
Table 5 The amino acid sequence identity of CYP150A20 with other P450 enzymes. Similar 
enzymes were found across species of Frankia (55-88% sequence identity), Mycobacterium 
(55-56% sequence identity), Blastococcus (55-64% sequence identity) and Streptomyces (55-
56% sequence identity). CYP150A1 was originally found in a Mycobacterium species.[60] 
Several Frankia species had P450s with a high similarity to CYP150A20 (sp. EUN1h, F. 
asymbiotica, F. saprophytica and sp. BMG5.36) which are all members of cluster 4 atypical 
Frankia (not shown). The P450 name is given when it has been assigned if not the Genbank 
protein ID or NCBI accession number is provided. [a] Max Score 835. 








OHV39124.1 Frankia sp. EUN1h 739 83% - - 
CYP150A23 Frankia sp. EuI1c 435 51% - - 
CYP150A22 Frankia sp. EuI1c 429 50% - - 
CYP150A21 Frankia sp. EuI1c 425 50% - - 
CYP150A5[32] Mycobacterium marinum 469 55% sclareol - 
CYP150A6[32] Mycobacterium marinum 442 50% - 6DCD 
SEP05279.1 Blastococcus endophyticus 553 64% - - 
KKD07836.1 Streptomyces sp. WM6386 468 56% - - 
CYP109B1[55] Bacillus subtilis 155 32% fatty acids 4RM4 
CYP108A1[53] Pseudomonas sp. 152 32% -terpineol 1CPT 
CYP1027H1 Frankia sp. EuI1c 105 27% ambroxide - 
 
Larger substrates with additional cyclic rings such as nootkatone induced a smaller shift of the 
Soret band (25%). Despite producing a smaller shift compared to several other substrates 
nootkatone exhibited the tightest binding to the P450 (Kd = 52 µM). α-Santonin shares 
structural features with nootkatone and induced a shift of 50% (Figure 3 and Figure S8 and S9) 
which was higher than any other substrate reported. However, its binding affinity was lower 
(Kd = 120 µM). Other large multiple ring structure compounds such as sclareolide and 
ambroxide were also tested with CYP150A20, but did not generate any spin state shift. 
 
Acyclic compounds with hydroxyl or ketone groups were also screened and the sesquiterpene 
cis-nerolidol bound to CYP150A20 with an affinity similar to those of the norisoprenoids (Kd 
= 111 µM, Figure 3). However, it induced a lower spin state shift at around 30%. Neryl acetate, 
which shares structural features to cis-nerolidol, induced a similar spin state shift (30%) and 
binding affinity (Kd = 123 µM, Figure S9 and S10). The cis-conformation of the double bond 
appears to be important for binding as the trans isomer of neryl acetate (geranyl acetate), did 
not result in a shift in the Soret band.  
 
CYP150A20 was able to bind a wide range of compounds but with relatively low affinity. 
While norisoprenoids bound to both CYP1027H1 and CYP150A20 the binding affinities for 
all substrates screened with CYP150A20 were lower compared to those found for CYP1027H1. 
In contrast to CYP1027H1. Compounds that do not have an oxygen containing functional 
group did not appear to bind to CYP150A20 with any significant affinity. Therefore while 
potential substrates have been determined, further screening and investigation is required to 




Figure 3 Compounds tested with CYP150A20. The percentage high spin and dissociation 




3.3.3 Investigation of Substrate Binding to CYP1074A2 
CYP1074A2 only shares high amino acid sequence identity to uncharacterised P450s in the 
NCBI database; the highest similarity was to CYP1074A1 also from Frankia sp. EuI1c at 71%. 
It is also closely related to other uncharacterised P450s from species of Mycobacteria and 
Blastococcus, with amino acid sequence identities ranging from 62% to 65%. However, 
CYP1074A2 was not closely related to any characterised P450, with the majority of the closest 
related P450s sharing  30% amino acid sequence identity (Table 6). For instance, CYP106A2, 
which has been reported to regioselectively hydroxylate steroids at the 15β position, shares 
only 26% of its sequence with CYP1074A2.[61] 
 
A range of compounds, including norisoprenoids, sesquiterpenoids, fatty acids, and polycylic 
aromatics, were screened with CYP1074A2 to assess if they could bind. While the majority of 
these classes of chemicals did not induce any noticeable spin state shifts (Supplementary 
Material) the steroid testosterone did. Testosterone bound tightly to CYP1074A2 and induced 
a complete spin state shift to the HS form (Kd = 7.6 µM,  95%, Figure 4 and Figure S11). The 
essentially complete type I spin state transition from 420 nm to 390 nm indicates that 
testosterone is positioned close enough to the heme centre to completely displace the distal 
water ligand. The low dissociation constant (Kd) demonstrates that the steroid molecule is held 
tightly within the active site of CYP1074A2. As a result of this, other steroids and steroid-like 
compounds were also tested for binding affinity towards CYP1074A2. 
 
Steroids with structural similarities to testosterone were also able to induce an almost complete 
shift ( 95%). These include progesterone (Kd = 2.9 µM), 4-androstene-3,17-dione (Kd = 8.3 
µM) and stanolone (Kd = 24 µM, Figure 4 and Figure S11). cis-Androsterone, a steroid similar 
to 4-androstene-3,17-dione, also induced a  95% spin state shift when added to CYP1074A2. 
However, the binding affinity (Kd = 204 µM, Figure S11) was almost two orders of magnitudes 
lower than with 4-androstene-3,17-dione. These compounds have the same general steroid ring 
structure consisting of three cyclohexane rings and one cyclopentane ring (Figure 4). Estrone 
and pregnenolone exhibited high binding affinity to CYP1074A2 but, unlike androsterone, 
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both induced a lower spin state shift (Figure 4). This infers that they are not positioned close 
enough to the iron-heme centre to completely displace the distal water ligand or that their mode 
of binding interferes with this step.  
 
Table 6 The amino acid sequence identity of CYP1074A2 with other P450s. These were 
determined using a BLAST sequence search on the NCBI database. Similar P450 enzymes 
were found in other strains of Blastococcus and Soliminas bacteria (with similar sequence 
identities as those presented below) as well as Algiphilus aromaticivorans (45% identity) and 
Nevskia soli (42% sequence identity). The P450 name is given when it has been assigned if not 
the Genbank protein ID or NCBI accession number is provided. [a] Max Score 863. 








CYP1074A1 Frankia sp. EuI1c 630 71% - - 
SEP19814.1 Blastococcus endophyticus 543 65% - - 
ORW83025.1 Mycobacterium riyadhense 540 62% - - 
SFF51085.1 Fontimonas thermophila 398 49% - - 
PPE73593.1 Solimonas sp. HR-BB 378 44% - - 
EIT67795.1 Hydrocarboniphaga effusa 369 45% - - 
PTU30351.1 Sinobacteraceae sp. 
GT1R17 
363 43% - - 
CYP167A1[62] Sorangium cellulosum 190 30% Epothilone 1PKF 
CYP105A1[63] Streptomyces griseolus 126 28% Vitamin D3 2ZBX 
CYP107H1[64] Bacillus subtilis 152 27% fatty acids 3EJD 
CYP106A2[61] Bacillus megaterium 152 26% steroids 4YT3 
 
 
Androsterone, estrone and pregnenolone are all sterols, characterised by a hydroxyl group at 
the C3 position. When compared to the steroids such as 4-androstene-3,17-dione, progesterone 
and testosterone, which have a ketone at this position and a different arrangement of the alkene 
double bond, the binding affinity to CYP1074A2 and/or the induced spin state shift were 
significantly decreased. For example, both progesterone and pregnenolone have very similar 
structures and while their binding affinity was similar, progesterone induced a significantly 
higher shift than pregnenolone ( 95% compared to 45%). Overall steroids with a hydroxyl 
substituent at the C3 position resulted in a lower spin state shift or binding affinity compared 
to those containing a carbonyl group at the same position. Thus the C3 substituent not only 
affects the ability of the steroid to displace the distal water ligand (or driving water bound heme 
to the HS form),[65-67] but also has a role in the affinity of the substrate binding. 
 
The steroid substrates with the highest affinity for CYP1074A2 contain an oxygen containing 
moiety at the C17 position. Each of the steroids which bound to CYP1074A2 contain an oxygen 
containing functional group on C3 and C17. Testosterone, which is structurally very similar to 
progesterone differing only at the C17 substituent, bound with an almost three-fold lower 
affinity highlighting the importance of this position. Dehydroepiandrosterone failed to induce 
any spin state shift in CYP1074A2 (Figure 4). It contains a C3 hydroxyl group and a C17 
ketone, but the location of the double bond has moved to the B ring of the steroid (Figure 4). 
The reason for the absence of a spectral change on addition of dehydroepiandrosterone is not 
clear as it is structurally very similar to other steroids tested but the combination of a C3 
hydroxy group, a C5-C6 alkene and a C17 ketone may not favour binding. The position of the 
cyclic double bond therefore appears to be important with the steroids. Those containing a 
conjugated double bond with the C3 ketone displayed the best binding parameters compared 
20 
 
to those which had saturated or aromatic A rings or the alkene in the B ring. For example, 
stanolone and 4-androstene-3,17-dione only differ by the addition of this double bond with the 
former having a decreased binding affinity. Cholesterol also did not induce any spin state shift 
in CYP1074A2. It does contain a C3 hydroxyl group but has a long branched carbon chain at 
the C17 position (Figure 4). 
 
Figure 4 Compounds identified which bind to CYP1074A2. The steroid ring labels and the 
carbon numbering scheme are provided. The percentage high spin and dissociation constants 
are presented as in Figure 2.  
 
 
The only non-steroid compound tested that induced a significant spin state shift was 
nootkatone. This sesquiterpenoid shares some structural similarities with steroids and induced 
a lower spin state shift and binding affinity compared to the best steroids (40%, Kd = 213 µM). 
It contains the same A and B cyclohexane ring skeleton and has a carbonyl group at C3 which 
is conjugated to an alkene (Figure 4). This provides additional evidence that these structural 
features are important for binding to CYP1074A2. However it lacks the cyclohexane (C) and 
cyclopentane (D) rings which make up the core structure of a steroid. Other substrates with 
structural similarities to nootkatone but which were larger, such as ambroxide and sclareolide, 
failed to induce any spin state shift.  
 
Overall although the structures of some of these steroids are very similar, the variation in the 
binding affinities, suggest that small structural differences play a role in binding. The 
cumulative effects of the substituents at C3 and C17, as well as the position of the double bond 
within the steroids contribute significantly to the binding affinity with CYP1074A2. Both the 
binding affinities and induced spin states of these substrates were higher than those screened 
with CYP1027H1 and CYP150A20 inferring that the likely physiological substrate of 




Soil-dwelling actinomycetes, such as Frankia, are known for being producers of many 
bioactive compounds and natural products. Recent bioinformatic analysis has revealed an 
abundance of secondary metabolic biosynthesis gene clusters in the other Frankia strains 
ACN14a, CcI3, and EAN1pec. These secondary metabolites and natural products include 
cyclic peptides, siderophores, aromatic compounds, signalling molecules and lipids. These 
gene clusters are also unique to individual strains of Frankia, suggesting species-specific 
biosynthetic diversity. The large number of P450s belonging to distinct families as well as the 
associated electron transfer partners found in different Frankia strains highlights the 
importance of these enzyme for forming novel natural products and secondary metabolites in 
these bacteria. Here we have identified and analysed the 68 cytochrome P450 encoding genes 
of Frankia sp. EuI1c along with associated ferredoxin (nine) and ferredoxin reductase (two) 
electron transfer partners. A selection of these P450s were produced, purified and screened for 
substrate binding with a range of different compounds. These results give an indication as to 
what their substrates may be (terpenoids and steroids). It is likely that steroids or related 
terpenoids are the physiological substrates of CYP1074A2 confirming the important role these 
enzymes have in Frankia sp. EuI1c secondary metabolism. 
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